Mark Machin, head of Canada’s largest pension fund, got a Covid-19 vaccine shot in the Middle East, according to people familiar with the matter, ahead of millions of Canadians waiting on one of the Western world’s slowest rollouts.

The 54-year-old chief executive of the $379 billion Canada Pension Plan Investment Board arrived earlier this month in the United Arab Emirates with his partner and received the first dose of a vaccine developed by Pfizer Inc. and Germany’s BioNTech SE, according to people familiar with the matter. He has told contacts he used local connections to obtain the vaccines, some of these people said, and he has remained in the U.A.E. and is due to receive his second dose in coming weeks, they said.

Mr. Machin didn’t comment when reached by phone and email. A spokesman for CPPIB and Mr. Machin said that he had “deeply personal” reasons for traveling to the U.A.E. “I can assure you that zero influence was applied or sought to be applied” in order for him to obtain the vaccine, the spokesman said.

The CPPIB is a crown corporation, meaning it is governed independently from the federal government but is the steward of pension obligations that are government mandated. It reports to a board of directors, who are selected by Canada’s minister of finance.

A spokeswoman for Canada’s ministry of finance said that “while the CPPIB is an independent organization, this is very troubling. The federal government has been clear with Canadians that now is not the time to travel abroad. We were not made aware of this travel.”

There is no evidence Mr. Machin, a British citizen, broke any laws to secure his dose. The Canadian government has urged residents to avoid overseas travel, but hasn’t banned it. The U.A.E., meanwhile, has said it is distributing vaccines to residents, a designation that foreigners can obtain through activities like investment, buying property or starting a local company. There is no evidence Mr. Machin is a resident.

The U.A.E. has made exceptions to its residency requirements. In January, the U.A.E.-sponsored cycling team that won the 2020 Tour de France—a group of around 60 mostly non-resident cyclists and staff—received doses of a Chinese-made vaccine in Abu Dhabi.

The U.A.E., a federation of seven emirates that includes the commercial hub of Dubai, has outpaced almost every country in the world with an ambitious vaccination campaign led by its quick embrace of the Chinese-made vaccine. Since December, the shot has been readily available and free for any adult resident or citizen. The country also offers the Pfizer-BioNTech vaccine, which has shown in clinical trials to be more effective, but it has been more scarce. It has been reserved mostly for people over the age of 60 or with chronic health conditions in the U.A.E.

As head of CPPIB, Mr. Machin is responsible for overseeing money set aside for retirement for roughly 20 million Canadians who contribute to the country’s public pension plan. CPPIB is one of the world’s largest pension funds, with sway in foreign markets and companies globally.

The Canadian fund in March 2020 held stakes in several U.A.E. companies including Abu Dhabi Commercial Bank PJSC and Emirates Telecommunications Group Co. PJSC, according to the fund’s annual disclosures of foreign stockholdings. Last year the fund invested in the $5.4 billion stock debut of Kuaishou Technology, a Chinese video-streaming startup, alongside Abu Dhabi Investment Authority, a big U.A.E. sovereign-wealth fund.

Mr. Machin’s vaccination, which hasn’t been previously reported, comes amid furor in other parts of the world over instances in which rich or well-connected people have been able to jump the line for a vaccine. Most of the world is carefully meting out doses to prioritize the most vulnerable, or those on the front lines fighting the pandemic.

Top Tweets About The Story

Top Stories